FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556605429> ?p ?o ?g. }

• W2556605429 endingPage "193" @default.
• W2556605429 startingPage "186" @default.
• W2556605429 abstract "Objective Magnetic resonance (MR)-guided vacuum-biopsy is technically demanding and may fail depending on target-lesion size or breast size, and location of lesions within the breast. We developed an MR-guided vacuum-assisted biopsy protocol that collects larger amounts of tissue, aiming at an at least partial or complete ablation of the target-lesion, just as it is intended during surgical (excisional) biopsy. Rationale is to avoid biopsy failures (false-negative results due to undersampling) by collecting larger amounts of tissue. We report on our experience with MR-guided vacuum-assisted large-volume breast biopsy (VALB) (MR-guided VALB) with regard to clinical success and complication rates. Materials Institutional review board–approved analysis of 865 patients with 1414 MR imaging (MRI)-only breast lesions who underwent tissue sampling under MRI guidance. Magnetic resonance–guided VALB was performed on a 1.5 T-system with a 9G system. Per target lesion, we collected at least 24 samples, with the biopsy notch directed toward the position of the target until on postbiopsy control imaging the target lesion appeared completely or at least greatly removed. The standard-of-reference was established by at least 24-months follow-up (for benign biopsy results), or results of surgical histology (for malignant or borderline results). We investigated the technical success rates as a function of factors that usually interfere with MR-guided vacuum biopsy. Results Target lesions were located in the central versus peripheral parts of the breast in 66.6% (941/1414) versus 33.6% (473/1414), occurred in large, intermediate, or small breasts in 22.7% (321/1414), 56.4% (797/1414), or 20.9% (296/1414), corresponded to nonmass enhancement (NME) versus mass enhancement (ME) in 64.0% (905/1414) vs. 36.0% (509/1414), with an average size of 23 mm for NME versus 9 mm for ME, respectively. Primary technical failures, that is, inability to reach the target lesion occurred in 0.2% of patients (2/865) and 0.1% of target lesions (2/1414). Successful biopsy, that is, an MR-guided VALB diagnosis matching with the standard of reference, was achieved in 99.5% (859/863) of patients and 99.7% (1408/1412) target lesions that had been amenable to MR-guided VALB. In 0.5% of patients (4/863) and 0.3% of target lesions (4/1412), a radiologic-pathologic mismatch suggested a false-negative biopsy, confirmed by secondary excisional biopsy. The likelihood of failure was independent of the lesion's location in the breast, breast size, target lesion size, or target lesion type (NME vs ME). None of the patients with benign MR-guided VALB diagnoses developed breast cancer at the biopsy site during follow-up of 2 years. None of the patients developed major complications. Conclusion Magnetic resonance–guided VALB is a safe procedure that is associated with a high success rate (99.7%) that is independent of the size, type, or location of a target lesion, or the size of the breast, and is associated with a very low complication rate." @default.
• W2556605429 created "2016-11-30" @default.
• W2556605429 creator A5012119257 @default.
• W2556605429 creator A5020244484 @default.
• W2556605429 creator A5051632825 @default.
• W2556605429 creator A5069853912 @default.
• W2556605429 creator A5070612619 @default.
• W2556605429 date "2017-03-01" @default.
• W2556605429 modified "2023-10-17" @default.
• W2556605429 title "Safety and Efficacy of Magnetic Resonance–Guided Vacuum-Assisted Large-Volume Breast Biopsy (MR-Guided VALB)" @default.
• W2556605429 cites W1824075891 @default.
• W2556605429 cites W1970415128 @default.
• W2556605429 cites W1976581691 @default.
• W2556605429 cites W1979069725 @default.
• W2556605429 cites W1989709157 @default.
• W2556605429 cites W2006073068 @default.
• W2556605429 cites W2008544857 @default.
• W2556605429 cites W2011944327 @default.
• W2556605429 cites W2028269636 @default.
• W2556605429 cites W2028918056 @default.
• W2556605429 cites W2046875354 @default.
• W2556605429 cites W2047476724 @default.
• W2556605429 cites W2064571738 @default.
• W2556605429 cites W2067937951 @default.
• W2556605429 cites W2068060219 @default.
• W2556605429 cites W2072964406 @default.
• W2556605429 cites W2077090894 @default.
• W2556605429 cites W2087163430 @default.
• W2556605429 cites W2087725556 @default.
• W2556605429 cites W2088779554 @default.
• W2556605429 cites W2106041529 @default.
• W2556605429 cites W2129755397 @default.
• W2556605429 cites W2140481377 @default.
• W2556605429 cites W2159779002 @default.
• W2556605429 cites W2166241254 @default.
• W2556605429 doi "https://doi.org/10.1097/rli.0000000000000331" @default.
• W2556605429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27861232" @default.
• W2556605429 hasPublicationYear "2017" @default.
• W2556605429 type Work @default.
• W2556605429 sameAs 2556605429 @default.
• W2556605429 citedByCount "18" @default.
• W2556605429 countsByYear W25566054292017 @default.
• W2556605429 countsByYear W25566054292018 @default.
• W2556605429 countsByYear W25566054292020 @default.
• W2556605429 countsByYear W25566054292021 @default.
• W2556605429 countsByYear W25566054292022 @default.
• W2556605429 countsByYear W25566054292023 @default.
• W2556605429 crossrefType "journal-article" @default.
• W2556605429 hasAuthorship W2556605429A5012119257 @default.
• W2556605429 hasAuthorship W2556605429A5020244484 @default.
• W2556605429 hasAuthorship W2556605429A5051632825 @default.
• W2556605429 hasAuthorship W2556605429A5069853912 @default.
• W2556605429 hasAuthorship W2556605429A5070612619 @default.
• W2556605429 hasConcept C121608353 @default.
• W2556605429 hasConcept C126322002 @default.
• W2556605429 hasConcept C126838900 @default.
• W2556605429 hasConcept C141071460 @default.
• W2556605429 hasConcept C143409427 @default.
• W2556605429 hasConcept C2775934546 @default.
• W2556605429 hasConcept C2777517664 @default.
• W2556605429 hasConcept C2780400711 @default.
• W2556605429 hasConcept C2780472235 @default.
• W2556605429 hasConcept C2781156865 @default.
• W2556605429 hasConcept C2781464078 @default.
• W2556605429 hasConcept C500558357 @default.
• W2556605429 hasConcept C530470458 @default.
• W2556605429 hasConcept C71924100 @default.
• W2556605429 hasConceptScore W2556605429C121608353 @default.
• W2556605429 hasConceptScore W2556605429C126322002 @default.
• W2556605429 hasConceptScore W2556605429C126838900 @default.
• W2556605429 hasConceptScore W2556605429C141071460 @default.
• W2556605429 hasConceptScore W2556605429C143409427 @default.
• W2556605429 hasConceptScore W2556605429C2775934546 @default.
• W2556605429 hasConceptScore W2556605429C2777517664 @default.
• W2556605429 hasConceptScore W2556605429C2780400711 @default.
• W2556605429 hasConceptScore W2556605429C2780472235 @default.
• W2556605429 hasConceptScore W2556605429C2781156865 @default.
• W2556605429 hasConceptScore W2556605429C2781464078 @default.
• W2556605429 hasConceptScore W2556605429C500558357 @default.
• W2556605429 hasConceptScore W2556605429C530470458 @default.
• W2556605429 hasConceptScore W2556605429C71924100 @default.
• W2556605429 hasIssue "3" @default.
• W2556605429 hasLocation W25566054291 @default.
• W2556605429 hasLocation W25566054292 @default.
• W2556605429 hasOpenAccess W2556605429 @default.
• W2556605429 hasPrimaryLocation W25566054291 @default.
• W2556605429 hasRelatedWork W1989155050 @default.
• W2556605429 hasRelatedWork W2011944327 @default.
• W2556605429 hasRelatedWork W2036332378 @default.
• W2556605429 hasRelatedWork W2063373969 @default.
• W2556605429 hasRelatedWork W2102916889 @default.
• W2556605429 hasRelatedWork W2556605429 @default.
• W2556605429 hasRelatedWork W2742769622 @default.
• W2556605429 hasRelatedWork W3027782007 @default.
• W2556605429 hasRelatedWork W3042478301 @default.
• W2556605429 hasRelatedWork W764551807 @default.
• W2556605429 hasVolume "52" @default.
• W2556605429 isParatext "false" @default.

• next